Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Susceptibilities of human cytomegalovirus clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosides.

Hwang JS, Schilf R, Drach JC, Townsend LB, Bogner E.

Antimicrob Agents Chemother. 2009 Dec;53(12):5095-101. doi: 10.1128/AAC.00809-09. Epub 2009 Sep 28.

2.

Brefeldin A inhibits expression of DNA packaging proteins and nucleocapsid formation of human cytomegalovirus.

Kregler O, Schilf R, Lander A, Bannert N, Bogner E.

FEBS Lett. 2009 Apr 2;583(7):1207-14. doi: 10.1016/j.febslet.2009.03.011. Epub 2009 Mar 14.

3.

Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus.

Kaspari M, Tavalai N, Stamminger T, Zimmermann A, Schilf R, Bogner E.

FEBS Lett. 2008 Mar 5;582(5):666-72. doi: 10.1016/j.febslet.2008.01.040. Epub 2008 Jan 31.

4.

Identification of acetylated, tetrahalogenated benzimidazole D-ribonucleosides with enhanced activity against human cytomegalovirus.

Hwang JS, Kregler O, Schilf R, Bannert N, Drach JC, Townsend LB, Bogner E.

J Virol. 2007 Nov;81(21):11604-11. Epub 2007 Aug 29.

Supplemental Content

Loading ...
Support Center